Shuttle Financial Statements From 2010 to 2025

SHPH Stock  USD 0.58  0.02  3.33%   
Shuttle Pharmaceuticals financial statements provide useful quarterly and yearly information to potential Shuttle Pharmaceuticals investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Shuttle Pharmaceuticals financial statements helps investors assess Shuttle Pharmaceuticals' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Shuttle Pharmaceuticals' valuation are summarized below:
Market Capitalization
2.5 M
Earnings Share
(4.25)
We have found one hundred twenty available fundamental trend indicators for Shuttle Pharmaceuticals, which can be analyzed and compared to other ratios and to its competition. Traders should compare all of Shuttle Pharmaceuticals current fundamentals against the fundamentals between 2010 and 2025 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 63.3 M. Enterprise Value is estimated to decrease to about 61.6 M
Check Shuttle Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Shuttle Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 3.1 M, Tax Provision of 0.0 or Depreciation And Amortization of 5.8 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.002 or PTB Ratio of 15.6. Shuttle financial statements analysis is a perfect complement when working with Shuttle Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Shuttle Pharmaceuticals Correlation against competitors.
For more detail on how to invest in Shuttle Stock please use our How to Invest in Shuttle Pharmaceuticals guide.

Shuttle Pharmaceuticals Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Current Liabilities1.1 M1.2 M754.7 K
Slightly volatile
Total Current Assets6.8 M6.4 M1.9 M
Slightly volatile
Common Stock19.020.0121.8 K
Slightly volatile
Property Plant Equipment90.6 K79 K75 K
Slightly volatile
Other Current Liabilities94.4 K99.4 K173.3 K
Slightly volatile
Accounts Payable276.2 K255 K192.7 K
Slightly volatile
Other Assets5.2 K5.8 K6.4 K
Slightly volatile
Other Current Assets87.7 K103 K171.6 K
Slightly volatile
Other Stockholder Equity15.1 M29.5 M6.3 M
Slightly volatile
Total Assets4.8 M6.8 M2.1 M
Slightly volatile
Short and Long Term Debt TotalM1.3 M879.9 K
Slightly volatile
Property Plant And Equipment Net246 K412.5 K211.4 K
Slightly volatile
Current Deferred Revenue333.8 K435.3 K276.1 K
Slightly volatile
Cash3.1 MM1.2 M
Slightly volatile
Non Current Assets Total250.3 K412.5 K216.9 K
Slightly volatile
Non Currrent Assets Other5.2 K5.8 K6.4 K
Slightly volatile
Cash And Short Term Investments4.4 M6.3 M1.6 M
Slightly volatile
Common Stock Shares Outstanding8.8 M15.9 M12.5 M
Slightly volatile
Liabilities And Stockholders Equity4.8 M6.8 M2.1 M
Slightly volatile
Non Current Liabilities Total608.1 K853.7 K291.6 K
Slightly volatile
Capital Lease Obligations430.6 K410.1 K216 K
Slightly volatile
Total Liabilities1.5 M1.7 M2.1 M
Slightly volatile
Property Plant And Equipment Gross456.1 K552.5 K412.1 K
Slightly volatile
Short and Long Term Debt551.8 K536.4 K632.9 K
Very volatile
Accumulated Other Comprehensive Income13.1 K14.7 K16 K
Slightly volatile
Capital Stock13814512.4 K
Slightly volatile
Short Term Debt593.8 K583.6 K694 K
Very volatile
Long Term Debt108.1 K121.6 K132.6 K
Slightly volatile

Shuttle Pharmaceuticals Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization5.8 K6.1 K43.1 K
Slightly volatile
Selling General Administrative930.2 K1.2 M549.6 K
Slightly volatile
Other Operating Expenses3.7 M6.8 M1.6 M
Slightly volatile
Research Development2.1 MM874.2 K
Slightly volatile
Cost Of Revenue5.8 K6.1 K46.9 K
Slightly volatile
Total Operating Expenses3.6 M6.8 M1.6 M
Slightly volatile
Reconciled Depreciation46.5 K77.3 K30.1 K
Slightly volatile
Selling And Marketing Expenses1.1 M1.2 M1.3 M
Slightly volatile

Shuttle Pharmaceuticals Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Borrowings725.4 K690.8 K308.4 K
Slightly volatile
Depreciation7.4 K7.8 K26.6 K
Pretty Stable
Total Cash From Financing Activities2.5 MM1.4 M
Slightly volatile
End Period Cash Flow2.3 MM1.1 M
Slightly volatile
Begin Period Cash Flow10.2 M9.7 M1.9 M
Slightly volatile
Stock Based Compensation155.6 K163.8 K429.4 K
Slightly volatile
Other Non Cash Items423.1 K602.2 K307 K
Slightly volatile
Dividends Paid321.7 K361.9 K394.5 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Dividend Yield0.0020.00220.0024
Slightly volatile
Average Payables249 K185.6 K210 K
Slightly volatile
Capex To Depreciation2.642.520.9822
Slightly volatile
Payables Turnover0.02630.02760.2101
Slightly volatile
Cash Per Share0.170.310.1092
Slightly volatile
Days Payables Outstanding14.3 K13.7 K4.3 K
Slightly volatile
Income Quality0.720.970.766
Slightly volatile
Current Ratio5.074.831.7292
Slightly volatile
Graham Number1.461.390.5428
Slightly volatile
Capex Per Share8.0E-40.00119.0E-4
Slightly volatile
Average Receivables8.1 K8.6 K36.7 K
Very volatile
Interest Debt Per Share0.220.210.0783
Slightly volatile
Debt To Assets0.20.211.6599
Slightly volatile
Days Of Payables Outstanding14.3 K13.7 K4.3 K
Slightly volatile
Ebt Per Ebit1.221.291.1304
Slightly volatile
Long Term Debt To Capitalization0.02580.0290.0316
Slightly volatile
Quick Ratio5.074.831.7292
Slightly volatile
Net Income Per E B T1.141.181.0595
Slightly volatile
Cash Ratio1.622.221.0545
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.321.151.3072
Slightly volatile
Debt Ratio0.20.211.6599
Slightly volatile

Shuttle Pharmaceuticals Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap63.3 M66.6 M3.2 B
Slightly volatile
Enterprise Value61.6 M64.9 M3.2 B
Slightly volatile

Shuttle Fundamental Market Drivers

Cash And Short Term Investments5.5 M

Shuttle Upcoming Events

20th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Shuttle Pharmaceuticals Financial Statements

Investors use fundamental indicators, such as Shuttle Pharmaceuticals' revenue or net income, to determine how well the company is positioned to perform in the future. Although Shuttle Pharmaceuticals' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue435.3 K333.8 K
Cost Of Revenue6.1 K5.8 K

Currently Active Assets on Macroaxis

When determining whether Shuttle Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Shuttle Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Shuttle Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Shuttle Pharmaceuticals Stock:
Check out the analysis of Shuttle Pharmaceuticals Correlation against competitors.
For more detail on how to invest in Shuttle Stock please use our How to Invest in Shuttle Pharmaceuticals guide.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Shuttle Pharmaceuticals. If investors know Shuttle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Shuttle Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.25)
Return On Assets
(1.12)
Return On Equity
(4.28)
The market value of Shuttle Pharmaceuticals is measured differently than its book value, which is the value of Shuttle that is recorded on the company's balance sheet. Investors also form their own opinion of Shuttle Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Shuttle Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Shuttle Pharmaceuticals' market value can be influenced by many factors that don't directly affect Shuttle Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Shuttle Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Shuttle Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Shuttle Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.